EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Alpha-tocopheryl quinone attenuates liver fibrosis through enriching Christensenella minuta and modulating bile acids metabolism via gut-liver axis

Jing Chen, Lu Zhang, Yuyan Chen, Yang Yan, Cuihua Lu

Phytomedicine · 2025

DOI: 10.1016/j.phymed.2025.157108 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2025. Verfasst von Jing Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, China; Research Cent…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Bile Acids and Salts, Liver Cirrhosis, Eubacteriales. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Liver fibrosis, characterized by the progressive accumulation of excessive extracellular matrix (ECM), remains a major global health issue with limited treatment options. The gut-liver axis, particularly the dynamics of gut microbiota and bile acids (BAs), plays a pivotal role in modulating hepatic fibrogenesis. Alpha-tocopheryl quinone (TQ), a vitamin E metabolite, exhibits antioxidative and anti-inflammatory properties; however, its impact on liver fibrosis remains unexplored. METHODS: A murine fibrosis model was induced using carbon tetrachloride (CCl4), coupled with gut microbiota depletion via antibiotic cocktail (Abx) and fecal microbiota transplantation (FMT) from cirrhotic donors, to evaluate TQ's therapeutic effects. Biochemical and histological analyses assessed liver injury and fibrosis, while 16S rRNA sequencing determined gut microbiota composition. BAs profiles were quantified using LC-MS/MS. Glycine-β-muricholic acid (Gly-MCA), a gut-restricted farnesoid X receptor (FXR) antagonist, was employed for investigating mechanistic pathways. RESULTS: TQ treatment significantly alleviated liver damage and fibrosis in CCl4-treated mice, with a notable reshaping of the gut microbiota, particularly an increased abundance of Christensenella minuta (C. minuta). Mechanistically, TQ activated the intestinal FXR/FGF15 pathway, resulted in reduced hepatic BAs synthesis and enhanced fecal excretion. Abx and FMT experiments confirmed the microbiota-dependent antifibrotic effects of TQ, with C. minuta identified as a key mediator. Co-treatment with Gly-MCA abrogated the protective effects of C. minuta, highlighting the critical role of intestinal FXR signaling. CONCLUSIONS: TQ attenuates liver fibrosis via modulation of gut microbiota, particularly enriching C. minuta abundance, and regulating BAs metabolism via activation of the intestinal FXR/FGF15 axis. These results establish TQ as a promising therapeutic targeting the gut-liver axis, with C. minuta identified as a pivotal mediator in BAs metabolism and fibrotic resolution. This study lays the groundwork for microbiota-centered therapeutic strategies against hepatic fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeBile Acids and SaltsLiver CirrhosisEubacterialesAnimalsMiceMaleLiverMice, Inbred C57BLCarbon TetrachlorideFecal Microbiota TransplantationReceptors, Cytoplasmic and NuclearReceptor, Farnesoid X-Activated

Stichwörter der Autor:innen

Alpha-tocopheryl quinoneBile acidsChristensenella minutaFarnesoid X receptorLiver fibrosis

Substanzen

Bile Acids and SaltsCarbon TetrachlorideReceptors, Cytoplasmic and NuclearReceptor, Farnesoid X-Activated

Autor:innen und Institutionen

  • Department of Gastroenterology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, China; Research Center of Clinical Medicine, Nantong University, Affiliated Hospital of Na…
  • Department of Hepatobiliary Surgery, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, China; Research Center of Clinical Medicine, Nantong University, Affiliated Hospital…
  • Department of Gastroenterology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, China. Electronic address: lch670608@sina.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Chen, J., Zhang, L., Chen, Y., Yan, Y., & Lu, C. (2025). Alpha-tocopheryl quinone attenuates liver fibrosis through enriching Christensenella minuta and modulating bile acids metabolism via gut-liver axis. Phytomedicine. https://doi.org/10.1016/j.phymed.2025.157108

Vancouver

Chen J, Zhang L, Chen Y, Yan Y, Lu C. Alpha-tocopheryl quinone attenuates liver fibrosis through enriching Christensenella minuta and modulating bile acids metabolism via gut-liver axis. Phytomedicine. 2025. doi:10.1016/j.phymed.2025.157108

BibTeX
@article{Chen2025,
  author = {Chen, Jing and Zhang, Lu and Chen, Yuyan and Yan, Yang and Lu, Cuihua},
  title = {Alpha-tocopheryl quinone attenuates liver fibrosis through enriching Christensenella minuta and modulating bile acids metabolism via gut-liver axis},
  journal = {Phytomedicine},
  year = {2025},
  doi = {10.1016/j.phymed.2025.157108}
}
Kostenlos starten →